Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Andreas Schneider, Reto Jost, Christoph Jordi & Jakob Lange. (2023) Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions. Expert Opinion on Drug Delivery 20:6, pages 815-830.
Read now
Read now
Andreas Schneider, Harald Kolrep, Hanns-Peter Horn, Christoph Jordi, Sina Gierig & Jakob Lange. (2023) Understanding patient preferences for handheld autoinjectors versus wearable large-volume injectors. Expert Opinion on Drug Delivery 20:2, pages 273-283.
Read now
Read now
Jesús Tornero Molina, Juan Carlos López Robledillo & Núria Casamira Ruiz. (2021) Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A Review. Drug, Healthcare and Patient Safety 13, pages 81-94.
Read now
Read now
Stephen P. Knowles, Marie A. Printz, David W. Kang, Michael J. LaBarre & Renee P. Tannenbaum. (2021) Safety of recombinant human hyaluronidase PH20 for subcutaneous drug delivery. Expert Opinion on Drug Delivery 18:11, pages 1673-1685.
Read now
Read now
Andreas Schneider, Harald Kolrep, Christoph Jordi, Philipp Richard, Hanns-Peter Horn & Jakob Lange. (2019) How to prevent medication errors: a multidimensional scaling study to investigate the distinguishability between self-injection platform device variants. Expert Opinion on Drug Delivery 16:8, pages 883-894.
Read now
Read now
Quentin Lohmeyer, Andreas Schneider, Christoph Jordi, Jakob Lange & Mirko Meboldt. (2019) Toward a new age of patient centricity? The application of eye-tracking to the development of connected self-injection systems. Expert Opinion on Drug Delivery 16:2, pages 163-175.
Read now
Read now
Bart J. F. van den Bemt, Lynda Gettings, Barbara Domańska, Richard Bruggraber, Irina Mountian & Lars E. Kristensen. (2019) A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience. Drug Delivery 26:1, pages 384-392.
Read now
Read now
Bernd Tischer & Andrea Mehl. (2018) Patients’ and nurses’ preferences for autoinjectors for rheumatoid arthritis: results of a European survey. Patient Preference and Adherence 12, pages 1413-1424.
Read now
Read now
Séverine Vermeire, François D’heygere, Antoine Nakad, Denis Franchimont, Fernand Fontaine, Edouard Louis, Philippe Van Hootegem, Olivier Dewit, Guy Lambrecht, Beatrijs Strubbe & Filip Baert. (2018) Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study. Patient Preference and Adherence 12, pages 1193-1202.
Read now
Read now
Thomas Thueer, Lena Birkhaeuer & Declan Reilly. (2018) Development of an advanced injection time model for an autoinjector. Medical Devices: Evidence and Research 11, pages 215-224.
Read now
Read now
Andreas E. Schneider & Jakob Lange. (2018) Pen devices for self-injection: contrasting measured injection force with users’ perceived ease of injection. Expert Opinion on Drug Delivery 15:2, pages 115-125.
Read now
Read now
Pablo Gurman, Albert Chi, Tiffany Hood, Micaela Reina, Yitzhak Rosen, Sebastian D’hers & Noel Elman. (2014) Prefilled devices for parenteral applications. Expert Review of Medical Devices 11:2, pages 205-223.
Read now
Read now
Hèctor Corominas, Silvia Garcia-Diaz, Lucinda Sanchez-Eslava & Ramon Fíguls. (2012) “Switching adalimumab from syringe to pen. Expected outcomes”. Expert Opinion on Biological Therapy 12:6, pages 805-806.
Read now
Read now
Joaquín Borrás-Blasco, Antonio Gracia-Pérez, J Dolores Rosique-Robles, M Dolores-Elvira Casterá & F Javier Abad. (2010) Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen. Expert Opinion on Biological Therapy 10:3, pages 301-307.
Read now
Read now
Robin K. Dore, Robert G. Feldman, Kathleen A. Taylor, Kyoungah See, Gail P. Dalsky & Margaret R. Warner. (2009) Patient experience with a new teriparatide delivery device. Current Medical Research and Opinion 25:10, pages 2413-2422.
Read now
Read now
Articles from other publishers (25)
Adrian D. Hobson, Jianwen Xu, Dennie S. Welch, Christopher C. Marvin, Michael J. McPherson, Bradley Gates, Xiaoli Liao, Markus Hollmann, Michael J. Gattner, Kristina Dzeyk, Hetal Sarvaiya, Vikram M. Shenoy, Margaret M. Fettis, Agnieszka K. Bischoff, Lu Wang, Ling C. Santora, Lu Wang, Julia Fitzgibbons, Paulin Salomon, Axel HernandezJr.Jr., Ying Jia, Christian A. Goess, Suzanne L. Mathieu, Shaughn H. Bryant, Mary E. Larsen, Baoliang Cui & Yu Tian. (2023) Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC). Journal of Medicinal Chemistry 66:17, pages 12544-12558.
Crossref
Crossref
Fatima Garcia-Villen, Idoia Gallego, Myriam Sainz-Ramos, Jorge Ordoyo-Pascual, Sandra Ruiz-Alonso, Laura Saenz-del-Burgo, Conor O’Mahony & Jose Luis Pedraz. (2023) Stability of Monoclonal Antibodies as Solid Formulation for Auto-Injectors: A Pilot Study. Pharmaceutics 15:8, pages 2049.
Crossref
Crossref
Adrian D. Hobson, Jianwen Xu, Christopher C. Marvin, Michael J. McPherson, Markus Hollmann, Michael Gattner, Kristina Dzeyk, Margaret M. Fettis, Agnieszka K. Bischoff, Lu Wang, Julia Fitzgibbons, Lu Wang, Paulin Salomon, Axel HernandezJr.Jr., Ying Jia, Hetal Sarvaiya, Christian A. Goess, Suzanne L. Mathieu & Ling C. Santora. (2023) Optimization of Drug-Linker to Enable Long-term Storage of Antibody–Drug Conjugate for Subcutaneous Dosing. Journal of Medicinal Chemistry 66:13, pages 9161-9173.
Crossref
Crossref
Ashwin Parchani, Aditya Sudan, Shiana Singh, Arpit Singh & Monika Pathania. 2023. Advances in Skeletal Muscle Health and Disease. Advances in Skeletal Muscle Health and Disease.
Adrian D. Hobson. 2023.
1
59
.
Alyson Yamaguchi, Jacques Van Dam, Arvinder K. Dhalla, Kyle Horlen, Mir Imran, April T. Vo & Mir A. Hashim. (2022) Transenteric delivery of antibodies via an orally ingestible robotic pill yields high bioavailability comparable to parenteral administration in awake canines. Frontiers in Drug Delivery 2.
Crossref
Crossref
Yifei Liu, Joakim Söderberg & Jingdong Chao. (2022) Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn’s Disease. Pharmacy 10:4, pages 87.
Crossref
Crossref
Roy M. Fleischmann, Amy E. Bock, Wuyan Zhang, Charles M. Godfrey, Ivana Vranic, Carol Cronenberger & Eva Dokoupilová. (2022) Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis. Rheumatology and Therapy 9:3, pages 839-850.
Crossref
Crossref
Donna S. Cox, Daniel F. Alvarez, Amy E. Bock & Carol L. Cronenberger. (2021) Randomized, Open‐Label, Single‐Dose, Parallel‐Group Pharmacokinetic Study of PF‐06410293 (adalimumab‐afzb), an Adalimumab Biosimilar, by Subcutaneous Dosing Using a Prefilled Syringe or a Prefilled Pen in Healthy Subjects. Clinical Pharmacology in Drug Development 10:10, pages 1166-1173.
Crossref
Crossref
Wenhui Zhang, Helen Tyrrell, Han Ting Ding, Jennifer Pulley, Audrey Boruvka, Rich Erickson, Mariam Abouhossein, Renato Ravanello & Meina Tao Tang. (2021) Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers. Advances in Therapy 38:5, pages 2418-2434.
Crossref
Crossref
Helen Tyrrell, Renato Ravanello, Jennifer Pulley, Meina Tao Tang, Wenhui Zhang, Mariam Abouhossein & Swati Tole. (2021) An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers. Advances in Therapy 38:5, pages 2406-2417.
Crossref
Crossref
Samvedna Saini & Yatender Kumar. 2021. Translational Biotechnology. Translational Biotechnology
233
266
.
Steve Fenwick, Kunal Thakur & Duncan Munro. (2019) Nurse and Patient Perceptions and Preferences for Subcutaneous Autoinjectors for Inflammatory Joint or Bowel Disease: Findings from a European Survey. Rheumatology and Therapy 6:2, pages 195-206.
Crossref
Crossref
Kunal Thakur, Anna Biberger, Alexandra Handrich & Mourad Farouk Rezk. (2016) Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe. Rheumatology and Therapy 3:2, pages 245-256.
Crossref
Crossref
Tamara del Río, Lara Valor, Inmaculada de la Torre & Esperanza Naredo. (2016) Impact of the Thickness of the Subcutaneous Tissue at the Site of Injection as Measured by Ultrasound on the Therapeutic Response to Subcutaneous anti-Tumour Necrosis Factor Drugs. Reumatología Clínica (English Edition) 12:5, pages 300-301.
Crossref
Crossref
Tamara del Río, Lara Valor, Inmaculada de la Torre & Esperanza Naredo. (2016) Impacto del grosor del tejido celular subcutáneo en el sitio de la inyección medido por ecografía sobre la respuesta terapéutica a fármacos antifactor de necrosis tumoral subcutáneos. Reumatología Clínica 12:5, pages 300-301.
Crossref
Crossref
Xiaowei WangJathushan PalasubramaniamYannik GkanatsasJan David HohmannErik WesteinRuchi KanojiaKaren AltDexing HuangFu JiaIngo AhrensRobert L. MedcalfKarlheinz PeterChristoph E. Hagemeyer. (2014) Towards Effective and Safe Thrombolysis and Thromboprophylaxis. Circulation Research 114:7, pages 1083-1093.
Crossref
Crossref
José G. B. Derraik, Marius Rademaker, Wayne S. Cutfield, Teresa E. Pinto, Sheryl Tregurtha, Ann Faherty, Jane M. Peart, Paul L. Drury & Paul L. Hofman. (2014) Effects of Age, Gender, BMI, and Anatomical Site on Skin Thickness in Children and Adults with Diabetes. PLoS ONE 9:1, pages e86637.
Crossref
Crossref
Cheng-Ping Mao, Martin R. Brovarney, Karim Dabbagh, Herbert F. Birnböck, Wolfgang F. Richter & Christopher J. Del Nagro. (2013) Subcutaneous versus Intravenous Administration of Rituximab: Pharmacokinetics, CD20 Target Coverage and B-Cell Depletion in Cynomolgus Monkeys. PLoS ONE 8:11, pages e80533.
Crossref
Crossref
Ray Bakhtiar. (2012) Therapeutic Recombinant Monoclonal Antibodies. Journal of Chemical Education 89:12, pages 1537-1542.
Crossref
Crossref
Wai H. Lim, Doris Chan, Neil Boudville, Susan Pellicano, Helen Herson, Harry Moody, Brian Hutchison, Marianne Snedeker & Gursharan Dogra. (2012) Patients' Perceptions of Subcutaneous Delivery of Darbepoetin Alfa by Autoinjector Prefilled Pen Versus Prefilled Syringe: A Randomized, Crossover Study. Clinical Therapeutics 34:9, pages 1948-1953.
Crossref
Crossref
Lucinda Sánchez-Eslava, Hèctor Corominas, Manel Riera & Ramon Fíguls. (2011) Experience of Monitoring Subcutaneous Biological Treatment (Adalimumab) by Nurses in Chronic Inflammatory Diseases. Reumatología Clínica (English Edition) 7:5, pages 349-350.
Crossref
Crossref
Lucinda Sánchez-Eslava, Hèctor Corominas, Manel Riera & Ramon Fíguls. (2011) Monitorización por enfermería de la administración de tratamientos biológicos subcutáneos (adalimumab) en enfermedades inflamatorias crónicas. Reumatología Clínica 7:5, pages 349-350.
Crossref
Crossref
Katharine A. Sheldon, Enrique Seoane‐Vazquez, Sheryl L. Szeinbach & Crystal Tubbs. (2010) Exploring risk and ease of use for insulin delivery by nurses. Journal of Evaluation in Clinical Practice 16:1, pages 199-201.
Crossref
Crossref
U. Sack & F. Emmrich. (2008) Monoklonale AntikörperMonoclonal antibodies. Der Internist 49:8, pages 919-928.
Crossref
Crossref